在青少年发病的真菌菌病的长期结果 fungoides
Rishabh Lohray1, Seda Purnak2, Auris Huen2
1Department of Dermatology, University of Texas MD Anderson Cancer Center; Department of Dermatology, Baylor College of Medicine.
Journal of the American Academy of Dermatology
|March 4, 2026
概括
青少年发病的真菌菌菌病 (jMF) 通常在早期阶段出现,并显示出出色的预后. 疾病的进展很少见,并不会导致儿童患者的死亡.
科学领域:
- 儿科瘤学 儿科瘤学
- 皮肤病学 皮肤病学
- 皮肤淋巴瘤研究研究
背景情况:
- 菌根性菌病是儿童最常见的皮肤T细胞淋巴瘤 (CTCL).
- 了解青少年发病真菌菌病 (jMF) 的长期结果对于儿科护理至关重要.
研究的目的:
- 描述被诊断患有真菌菌菌病的儿科患者的长期结果.
- 为了评估青少年发病的真菌菌菌病的疾病进展和生存率.
主要方法:
- 在1987年至2023年间诊断出jMF的118名儿科患者的回顾性分析.
- 数据收集包括通过医疗记录和远程医疗的临床,组织病理和生存信息.
- 阶段进展定义为TNMB阶段化或疾病死亡的进展.
主要成果:
- 97%的患者出现了早期 (IA-IIA) 的jMF.
- 疾病进展发生在13%的患者中,疾病进展的中位时间为2年.
- 优秀的存活率:5年 (99%) 和10年 (98%) 的整体存活率;100%的疾病特异性存活率在5年和10年.
结论:
- 青少年发病的真菌菌菌病 (jMF) 通常表现为早期疾病.
- jMF显示出出色的预后,具有高的整体和疾病特异性存活率.
- 疾病进展不常见,并且在这个队列中与疾病特异性死亡率无关.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Cystic Fibrosis: Management
593
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
593
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
582
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
582
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
616
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
616

